Hunan Nucien Pharmaceutical Co (SHSE:688189) Dividend Yield %: 0.00% (As of Jun. 28, 2026)


SHSE:688189 Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
53 GF Score
Price ¥5.92
GF Value ¥2.38
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Hunan Nucien Pharmaceutical Co Dividend Yield %?

Hunan Nucien Pharmaceutical Co SHSE:688189 -2.47% 53 Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus rates SHSE:688189 with a GF Score™ of 53/100 and a GF Value™ of ¥2.38 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 517 Drug Manufacturers companies, Hunan Nucien Pharmaceutical Co ranks worse than 193423.4% on this metric.

As of today (2026-06-28), the Trailing Annual Dividend Yield of Hunan Nucien Pharmaceutical Co is 0.00%.

The historical rank and industry rank for Hunan Nucien Pharmaceutical Co's Dividend Yield % or its related term are showing as below:

During the past 10 years, the highest Dividend Yield of Hunan Nucien Pharmaceutical Co was 1.99%. The lowest was 0.81%. And the median was 1.12%.

SHSE:688189's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.06
* Ranked among companies with meaningful Dividend Yield % only.

Hunan Nucien Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00.

As of today (2026-06-28), the Forward Dividend Yield % of Hunan Nucien Pharmaceutical Co is 0.00%.

Hunan Nucien Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2026 was ¥0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Hunan Nucien Pharmaceutical Co  (SHSE:688189) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Hunan Nucien Pharmaceutical Co Dividend Yield % Related Terms


Hunan Nucien Pharmaceutical Co Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Hunan Nucien Pharmaceutical Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Nucien Pharmaceutical Co Dividend Yield % Chart

Hunan Nucien Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.00 0.00 0.00 0.00

Hunan Nucien Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SHSE:688189 vs ZTS: Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Nucien Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Nucien Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Nucien Pharmaceutical Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Hunan Nucien Pharmaceutical Co's Dividend Yield % falls into.


SHSE:688189
53GF Score
Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hunan Nucien Pharmaceutical Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Hunan Nucien Pharmaceutical Co (SHSE:688189) has a Dividend Yield % of 0.00% as of Jun. 28, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Hunan Nucien Pharmaceutical Co and its competitors. Over the past decade, Hunan Nucien Pharmaceutical Co's Dividend Yield % has ranged from 0.81 to 1.99. According to the industry distribution chart, Hunan Nucien Pharmaceutical Co ranks #999999 out of 517 companies in the Drug Manufacturers industry.
Is Hunan Nucien Pharmaceutical Co's Dividend Yield % too high?
Hunan Nucien Pharmaceutical Co's current Dividend Yield % is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 1.99. Based on the distribution chart, Hunan Nucien Pharmaceutical Co ranks #999999 out of 517 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hunan Nucien Pharmaceutical Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Nucien Pharmaceutical Co's Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hunan Nucien Pharmaceutical Co ranks #999999 out of 517 companies for Dividend Yield %. This places Hunan Nucien Pharmaceutical Co in the lower half of its industry. The industry median Dividend Yield % is 2.06. Historically, Hunan Nucien Pharmaceutical Co's own Dividend Yield % has ranged from 0.81 to 1.99 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.06, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Hunan Nucien Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hunan Nucien Pharmaceutical Co's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Nucien Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co (SHSE:688189) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.38, compared to a current price of ¥5.92 — trading 148.7% above its estimated fair value. The current Dividend Yield % is 0.00%. Hunan Nucien Pharmaceutical Co's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Hunan Nucien Pharmaceutical Co (SHSE:688189), the current Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hunan Nucien Pharmaceutical Co (SHSE:688189) Overvalued in 2026?

Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥5.92 is trading 148.7% above its estimated GF Value™ of ¥2.38. GuruFocus considers Hunan Nucien Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:688189:

  • Dividend Yield %: 0.00%
  • GF Value™: ¥2.38 vs. price of ¥5.92 (148.7% above fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hunan Nucien Pharmaceutical Co Business Description

Address No. 1 Kangli Road, Liuyang Economic and Technological Development Zone, Hunan Province, Changsha, CHN, 510100
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields. The company's business scope includes the manufacturing and sales of chemical pharmaceutical preparations, chemical pharmaceutical raw materials, biological drugs, chemical reagents, and auxiliaries.
53GF Score

Get the complete analysis for SHSE:688189

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.92
Price
¥2.38
GF Value